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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S295ĂConclusion: The effectiveness of HA injections for the treatment of
patients with knee OA remains unclear. Some researchers reported that
the volume of SF and the molecular weight of C4S, C6S and KS decreased,
and themolecular weight of HA increased after ﬁveweekly injections. Also
they reported that clinical symptoms improved after HA injections. Our
results showed that the ROM improved with the decrease of SF after ﬁve
weekly injection. The destruction of proteoglycan in articular cartilage
resulted in the decrease of the molecular weight of C4S, C6S, and KS.
However, our results showed that molecular weight of HA, C4S, C6S and KS
before HA injection did not change after HA injection. A possible reason of
the difference between previous and this studies might be related with the
small number of this study. In summary, our study showed that clinical
symptoms and ROM improved with the decrease of effusion, although the
destructive products of cartilage did not change after ﬁve weekly HA
injections. In future, we should enrolled many patients with knee OA and
investigate the relationship between the proceeding of knee OA and the
destructive products of cartilage.
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DESIGN RATIONALE AND EARLY CLINICAL / SURGICAL OBSERVATIONS
WITH A TISSUE SPARING STEM FOR THA IN OSTEOARTHRITIS
T. McTighe 1, D. Brazil 2. The TSI Study Group1 Joint Implant Surgery and
Res. Fndn., Chagrin Falls, OH, USA; 2 Joint Implant Surgery and Res. Fndn.,
Sydney, Australia
Abstract: Architectural changes occurring in the proximal femur after
THA continues to be a problem. Proximal stress shielding occurs
regardless of ﬁxation method. The resultant bone loss can lead to implant
loosening and or breakage of the implant. We are seeing younger
patients with higher levels of physical activity as compared to just
a decade ago. A tissue sparing total hip stem provides for less tissue
damage, a quicker rehab and leaves behind more infrastructure in case of
future revision surgery.
Introduction: Patients today demand more out of the hip recon-
struction and their increase activity places a higher demand on the
implant. A number of the current short stems introduced into the
market are no more than standard stems cut short. There is concern
with the increase in younger and more active patients that these
modiﬁed short stems be adequate to resist the increased biome-
chanical loads placed on them?
The purpose of this paper is to review a new novel neck sparing total hip
stem and the method by which this stem achieves implant/bone stability,
surgical technique required, and observations as to early clinical outcomes.
Material: There have been 750 stems implanted with this novel neck
sparing stem design since April 2010 with 600 from the surgical team
(seven) posted for review. . All seven were part of the initial surgical team
to aid in designing and ﬁne-tuning of surgical instruments. Typical patient
proﬁle showed two-thirds being female with an age range overall between
17 to early 90s. 90%were treated for OA. This stem has been used in all Dorr
bone classiﬁcations (A, B, &C). Two surgical approaches were utilized the
single anterior incision and standard posterior incision.
Results: Anterior Approach Dislocations ¼ 2 Stem Revisions ¼ 3 Aseptic
Loosening ¼ 1 Superﬁcial Infection ¼ 2 Septic Loosening ¼ 0 Leg / Length
Discrepancy +/- 7 mm ¼ 9 / 0.3% Occult fracture distal end of stem ¼ 1
Calcar Fractures wired ¼ 2 Calcar Fractures not wired ¼ 3 Hip pain ¼ 1
Subsidence > 5mm ¼ 3 Intra-op femoral perforation ¼ 3 Intra-op calcar
fractures resulting in stem bailout ¼ 0 Posterior Approach Dislocations¼ 2
Stem Revisions ¼ 1 Aseptic Loosening ¼ 0 Septic Loosening ¼ 1 Superﬁcial
Infection¼ 0 Leg / length Discrepancy +/- 7 mm¼ 3 / .013% Fractures distal
¼ 0 Calcar Cracks wired ¼ 0 Calcar Cracks not wired ¼ 1 Hip pain ¼ 1(process of being worked up/ potential spine problem) Subsidence > 5mm
¼ 0 Intra-op calcar fractures resulting in stem bailout ¼ 2
Discussion: There is a short learning curve for the surgeon (2-3 cases)
and an easy transition for the O.R. surgical team with only one pan of
instruments. Six of the seven surgeons feel that these patients with this
short curved neck-sparing stem have gotten back to full weight bearing
and a full active life style quicker than their conventional cementless
THA. One surgeon gauges them as equivalent to his conventional stems.
All feel that there is less blood loss and operative times have been
reduced.
The few explants have proven to be easily converted to a primary stem for
revisions. Two intra-operative calcar fractures resulted in a bail out to
a conventional primary cementless stem. The modular neck has proven to
be beneﬁcial in a couple of cases for access to the socket in revision situ-
ations. The modularity of the neck also helps reducing risk of mechanical
impingement.
There have been minor incidence of over lengthening the leg (11) greater
than 7 mm however; none have had to be revised.
We are encouragedwith our initial clinical / surgical observations (patients
are happy) and believe the potential and real beneﬁts warrant not only




INTRA-ARTICULAR GROWTH HORMONE INJECTIONS REGROW
CARTILAGE, INCREASE MOTION AND REDUCE PAIN IN 93 PER CENT.
OF ARTHRITIC ANKLES.
A.R. Dunn. Mt. Sinai Med. Ctr., Miami Beach Florida, FL, USA
Purpose: Purpose: The author uses intra-articular growth hormone(iagh)
injections as a treatment for osteoarthritis(OA) of the ankle. Results of this
treatment were ﬁrst observed in the author's studies of cartilage healing
following intra-articular growth hormone(IAGH) injections in surgically
debrided knees in mature rabbits. Iagh causes Pre-natal Developmental
Healing(PDH) of cartilage which grows fetal cartilage by recapitulation of
the cascades of development. PDH involves no inﬂammation and produces
no scar tissue. The method was translated to the iagh treatment of 14
patients with advanced OA of the ankle. Age ranged from 37 to 76 years.
There were 10 males and 4 females followed 2 to 4 years post treatment.
Iagh treatment has no side effects, complications, infections, or deaths.
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S296Arthroplasty and arthrodesis, the standard treatments, were avoided. Iagh
treatment costs one-fourth the cost of the standard treatments and has no
side effects, complications or deaths.
Method: Pre-treatment evaluations included history, physical examina-
tion, MRI's, X-rays and blood tests including cbc, comprehensive metabolic
proﬁle, thyroid, IGf-1, and for females, estradiol, mammograms, CEA and
ca125; and for males psa and testerone. Sixty per cent of the joints
required arthroscopic debridement. Half of the patients required open
excision of an osteophyte on the dorsum of the talar neck which caused
impingement. Intra-articular injections of 5.0 mgm of Human Growth
hormone(Omnitrope, Sandoz) were give weekly for 5 to 12 weeks. I.A.
injections were made through an anterior approach after sterile prepara-
tion and local anesthetic injection in the subcutaneous tissue. No immo-
bilization was used. Patients were kept non weight bearing on the treated
side using 2 crutches and practiced active and passive assistive range of
motion exercises twice daily at home and for the duration of injections
plus an additional 4 weeks. Patients were encouraged to swim one hour
daily. During treatment a patellar tendon bearing(PTB) brace was con-
structed and carefully ﬁtted. This brace was worn for 6 months after
completion of injections. Continuous passive motion and physiotherapy
were not used.
Results: Evaluations were made with serial X-ray joint space measure-
ment; range of motion measurement with a goniometer; and visual
analogue scale for pain scores. Thirteen patients(93%) had good to
excellent results. One patient (7%) had no improvement and motion
remained 0 degrees. It is unknown whether this patient had additional
treatment in the future. Pain scores pre-treatment ranged from 4 /10 to 9
/10. Post-treatment pain scores ranged from 0/10 to 4/10; the average
loss of pain was 5 /10. Pre-treatment motion ranged from 0 to 30
degrees. Post-treatment motion ranged from 0 to 50 degrees with and
average of 14 degrees increase. There were no complications, side effects,
infections, increased stiffness or pain; DVT, pulmonary embolism; or
deaths.
Conclusion: 93% (13 of 14) of the patients treated with iagh injections
avoided arthroplasty and arthrodesis, the standard and more expensive
treatments. No patient became worse. The safety, high per cent. of success,
and its decreased cost recommends this treatment prior to considering
surgery. This is a Level IV Study.
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EARLY RESULTS OF MINIMALLY INVASIVE MEDIAL
UNICOMPARTMENTAL KNEE ARTHROPLASTY ASSOCIATED WITH
OBESITY
G. Sohár, L. Mécs, F. Greksa, K. Tóth. Univ. of Szeged, Szeged, Hungary
Purpose: The purpose of this study was to analysis the relationship
between the short-term results of unicondylar arthroplasty procedures
and obesity. Unicompartmental replacement of the osteoarthritic knee is
widely used in both the United States and Europe. Indications for uni-
compartmental knee arthroplasty usingminimally invasive techniques has
been expanded. The advantages of this concept that only the abnormal
joint surfaces are removed, the total amount of bone excised is minimal,
and the amount of foreign material is also minimal.
Methods: All the patients had predominantly unicompartmental knee
osteoarthritis. Obesity was deﬁned as body mass index (BMI) greater than
35 kg/m2. 96 unicondylar arthroplasties were performed in 2010 for
osteoarthritis at the Orthopedic Department. There were 62 women and
34 men. The average age was 62 years (range, 52 to 74 years). Only the
medial compartment was replaced. No other alternative procedures were
done on the patella. When associated patellofemoral osteoarthritis was
found total knee arthroplasty was performed. The follow-up examination
included the American Knee Society score, physical assessment, and
radiological evaluation. Pre-, post-operative and follow-up radiographs
were analyzed to assess further degenerative changes. The relationship
between the clinical result and body mass index was analysed.
Results: Thirtytwo patients had BMI's higher than 35 kg/m2, the
remaining 64 patients had lower BMIs. In both BMI group, 1-1 knees were
revised to total knee arthroplasty. The current two-year survival rate for
ﬁxed bearing unicondylar knee arthroplasty is 98%.
Conclusions: Properly selecting the patient for unicondylar knee arthro-
plasty is important in providing similar short term outcome for obese and
non-obese patients. The unicondylar knee arthroplasty is a less extensive
surgical option, which results in a faster postoperative recovery. It is
designed to treat knee joints with osteoarthritis limited to one compart-
ment. There was no signiﬁcant difference between the American Knee
Society scores between the two surviving BMI groups. All components
were radiographically stable.
